Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Nu Skin Enterprises, Inc.
NUS
NYSE·Consumer Defensive·Household & Personal Products·Mkt cap $254.9M
$5.01
▼ -4.57%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$4.89 - $14.62
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 40.5% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
6 reasons
- Proprietary ageLOC technology platform providing differentiated anti-aging solutions
- Established direct-to-consumer sales model with global distributor network
- Strong brand portfolio (Nu Skin, Pharmanex, ageLOC) with decades of brand equity
- Integrated product ecosystem combining skincare, devices, and supplements for customer loyalty
- Significant R&D capabilities in skincare and nutritional supplement development
- Physical retail presence and service centers in high-growth Mainland China market
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Premium gross margins (69%)
Value
Deep value opportunity - significant discount to Household Products peers
Momentum
Falling
-29.1% over 3m
Quality
Excellent
Strong fundamentals
Dividend
Solid
4.57% yield
Smart-money signal
Who's buying NUS right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: May 6, 2026
MAY 7, 2026
Reported EPS of $0.14 vs $0.15 consensus (-6.7% surprise). Revenue of $320.6M vs $329.7M expected (-2.8%).
EPS surprise · last 4Q
0 of 1 beats
Q2 26
-6.7%
Next: May 6, 2026
Revenue trend · last 8Q
—
—
-9%
-13%
-12%
-15%
-17%
-12%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$439.1M
$430.1M
$445.6M
$364.5M
$386.1M
$364.2M
$370.3M
$320.6M
Margins · last 8Q
Gross
—
Operating
—
Profit
0.6%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
No analyst coverage on file for this stock yet.